DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Awada A, Colomer R, Inoue K, Bondarenko I, Badwe RA, Demetriou G. et al.
Neratinib plus paclitaxel vs. trastuzumab plus paclitaxel in previously untreated metastatic ERBB2-positive breast cancer: The NEfERT-T randomized clinical trial.
JAMA Oncol 2016;
2: 1557-64
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.